Literature DB >> 24184253

Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis.

Bertram Pitt1, Patrick Rossignol2.   

Abstract

Entities:  

Keywords:  cardiovascular and cerebrovascular event; hemodialysis; spironolactone

Mesh：

Substances：

Year:  2013        PMID： 24184253     DOI： 10.1016/j.jacc.2013.09.057

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Chronic Kidney Disease.

Authors:  Mohammad Saud Khan; Muhammad Shahzeb Khan; Abdelmoniem Moustafa; Allen S Anderson; Rupal Mehta; Sadiya S Khan
Journal:  Am J Cardiol       Date:  2019-11-19       Impact factor: 2.778

Review 2.  Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.

Authors:  Srisakul Chirakarnjanakorn; Sankar D Navaneethan; Gary S Francis; W H Wilson Tang
Journal:  Int J Cardiol       Date:  2017-01-04       Impact factor: 4.164

3.  Association of Mineralocorticoid Receptor Antagonists With the Mortality and Cardiovascular Effects in Dialysis Patients: A Meta-analysis.

Authors:  Wen-Jun Gou; Fa-Wei Zhou; Rui Providencia; Bo Wang; Heng Zhang; Shou-Liang Hu; Xiao-Li Gao; Yan-Hong Tuo; Yong Zhang; Tian Li
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

4.  Aldosterone induces albuminuria via matrix metalloproteinase-dependent damage of the endothelial glycocalyx.

Authors:  Matthew J Butler; Raina Ramnath; Hiroyuki Kadoya; Dorinne Desposito; Anne Riquier-Brison; Joanne K Ferguson; Karen L Onions; Anna S Ogier; Hesham ElHegni; Richard J Coward; Gavin I Welsh; Rebecca R Foster; Janos Peti-Peterdi; Simon C Satchell
Journal:  Kidney Int       Date:  2018-10-31       Impact factor: 10.612
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.